ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Timber Pharmaceuticals Inc

Timber Pharmaceuticals Inc (TMBR)

0.3426
0.00
( 0.00% )
Updated: 19:00:00

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.3426
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.3426
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

TMBR Latest News

Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American

WARREN, NJ, Nov. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. (NYSE American: TMBR), a clinical-stage biopharmaceutical company focused on the development and...

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

WARREN, NJ, Sept. 18, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to be Acquired by LEO Pharma

Transaction Provides Timber Stockholders with Upfront Cash Consideration and Downstream Value through Contingent Value RightsTotal Transaction Value of up to $36 millionTransaction Expected to...

Timber Pharmaceuticals Discloses Communication From NYSE American

WARREN, NJ, July 03, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage biopharmaceutical company...

Timber Pharmaceuticals to Present Interim Analyses From Phase 3 ASCEND Study of TMB-001 in Congenital Ichthyosis

- First Presentation of Data From Phase 3 ASCEND Study Will Feature Pharmacokinetic Results That Indicate Minimal Systemic Absorption of Isotretinoin - - Data to be Presented at the Society for...

Timber Pharmaceuticals Announces FDA Grant of CARC Waiver for TMB-001

- Phase 3 ASCEND study of TMB-001 (topical isotretinoin) for the treatment of congenital ichthyosis is 70% enrolled - WARREN, NJ, June 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Timber...

Timber Pharmaceuticals Provides Business Update and Announces First Quarter 2023 Financial Results

- Timber has now Enrolled Over 60% of Patients for Pivotal TMB-001 Phase 3 ASCEND Clinical Trial - WARREN, NJ, May 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc...

Timber Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Year End 2022 Financial Results

- Lead asset TMB-001 is only compound to receive official orphan drug designation from European Commission for two severe subtypes of congenital ichthyosis, ARCI and XLRI - - Timber has enrolled...

Timber Pharmaceuticals Announces Publication of Sub-Analysis of Phase 2b CONTROL study in Clinical and Experimental Dermatology

- Treatment with TMB-001 demonstrated greater proportions of participants achieving primary and key secondary endpoints versus vehicle regardless of the subtype of congenital ichthyosis - BASKING...

Timber Pharmaceuticals Receives European Orphan Drug Designation for TMB-001 in X-Linked Recessive Ichthyosis

Company Progressing With Pivotal Phase 3 ASCEND Clinical Trial in the U.S., Canada, Italy, France, and Germany BASKING RIDGE, NJ, Feb. 24, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TMBR - Frequently Asked Questions (FAQ)

What is the current Timber Pharmaceuticals share price?
The current share price of Timber Pharmaceuticals is $ 0.3426
What is the 1 year trading range for Timber Pharmaceuticals share price?
Timber Pharmaceuticals has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAPAKairos Pharma Ltd
$ 2.38
(145.36%)
92.42M
TPETTrio Petroleum Corp
$ 2.55
(32.81%)
10.79M
BATLBattalion Oil Corporation
$ 2.2364
(27.07%)
396.44k
ROLRHigh Roller Technologies Inc
$ 4.16
(23.08%)
77.4k
EONREON Resources Inc
$ 1.11
(20.65%)
6.91M
LODEComstock Inc
$ 0.277999
(-47.55%)
31.28M
OPTTOcean Power Technologies Inc
$ 0.821
(-28.61%)
28.39M
CTMCastellum Inc
$ 0.7511
(-27.78%)
6.78M
AEONAEON Biopharma Inc
$ 0.141
(-24.03%)
16.53M
HCWCHealthy Choice Wellness Corp
$ 1.49
(-19.02%)
1.13M
KAPAKairos Pharma Ltd
$ 2.38
(145.36%)
92.42M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
$ 6.507
(0.73%)
62.28M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 27.3188
(-2.64%)
52.8M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 2.5101
(-0.19%)
41.71M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
$ 3.345
(5.69%)
39.76M

Discussion

View Full Feed
bucks2pennies bucks2pennies 4 minutes ago
can, may just be the ingredient to push the pps up! The rise in the bid just might be the indicator that your question may be answered.
GTCH
biotech-1953 biotech-1953 4 minutes ago
I think it is correct: there are no trials listed outside China. Overall, Kailera licensed 3 drugs from Jiangsu Hengrui. KAI-9531 / HRS9531 has been tested only in China and Phase 2 trials of 36 weeks (with 12 weeks of titration) are complete. Oral version Kai-7535 is close to the end of Phase
GLP
ducci1 ducci1 4 minutes ago
SPX--Resistance 5829---Pivot--5841----5 min Red Line 5848 ??
SPY
skitahoe skitahoe 4 minutes ago
In a Phase 4 patient pay for the drug, but results are reported.   To me, the trials and approval process should be shorter and less expensive, but all approvals should be followed by a Phase 4.

Gary 
AVXL
Golden Cross Golden Cross 4 minutes ago
$LITM Over 108M Shares Traded On News Today!
https://www.juniorminingnetwork.com/junior-miner-news/press-releases/3067-nasdaq/litm/173458-snow-lake-discovers-gallium-in-ontario-a-critical-mineral-driving-ai-and-data-center-advancements.html

#Gallium #Uranium #Lithium
LITM
Lone Clone Lone Clone 4 minutes ago
FPX Nickel Announces Results of Baptiste Nickel Project Economic Impact Study

https://www.newswire.ca/news-releases/fpx-nickel-announces-results-of-baptiste-nickel-project-economic-impact-study-874838698.html

News provided by FPX Nickel Corp. Jan 13, 2025, 07:00 ET
glenn1919 glenn1919 4 minutes ago
BAER...............................https://www.globenewswire.com/news-release/2025/01/13/3008492/0/en/Bridger-Aerospace-Confirms-the-Mobilization-of-Super-Scooper-Aircraft-to-California-to-Assist-in-Firefighting-Efforts.html
Lite Lite 4 minutes ago
How many people in this company?

https://www.fhfaoig.gov/sites/default/files/WPR-2023-001.pdf



martyDg martyDg 5 minutes ago
Of course, you have to believe. That's all you guys do believe to every single positive words from the people here. What else can you do? And of course, you will be fine if he misses. You forgive him until he finally gets it right (he's got 12 tries anyway). And you'll pat him on the back and praise
NWBO
richme richme 5 minutes ago
ALL SELLS. The fact that they are all sells is not very assuring. The "fact" that the trades are or mostly sells and selling ahead the 14th or 15th news can be read negatively. What is your thinking on this?
ZHUD
lakers17 lakers17 5 minutes ago
My OTC penny stocks have picked up a little in January after a horrible December because of tax selling. Big OTC winner for me so far is UMAV at .057, a 6X for me as I bought at .009 average. Riding freebies now and some profit in pocket. Same rules in playing the OTC apply to playing crypto. Al
UMAV
TMaga TMaga 5 minutes ago
Healthy Choice Wellness Corp. Announces Record Fourth Quarter and Year-End 2024 Sales and Gross Margin Performance
Really!!! Where is our money. We know how much you made Holman (Clyde)
HCWC
Newc Newc 5 minutes ago
$capc Imagine a volume day and news float is tiny here and it’s being accumulated it seems and moving upward looking at chart.


“The cancellation agreements were part of an effort by the Company to eliminate debts in order to enhance its prospects for attracting funding or a c
CAPC
BottomBounce BottomBounce 5 minutes ago
$ANF Total Debt (mrq) $890.85M
ANF
Golden Cross Golden Cross 5 minutes ago
$LITM Over 108M Shares Traded On News Today!
https://www.juniorminingnetwork.com/junior-miner-news/press-releases/3067-nasdaq/litm/173458-snow-lake-discovers-gallium-in-ontario-a-critical-mineral-driving-ai-and-data-center-advancements.html

#Gallium #Uranium #Lithium
LITM
RSuave25020 RSuave25020 5 minutes ago
I agree about the word search issue which is why I asked the second question to widen the search. The magnetic portion of amorphous metals is still an interesting area nonetheless and I see it as a good way to diversify out of the expensive metals into something more cost effective and field related
LQMT
Newc Newc 6 minutes ago
$capc Imagine a volume day and news float is tiny here and it’s being accumulated it seems and moving upward looking at chart.


“The cancellation agreements were part of an effort by the Company to eliminate debts in order to enhance its prospects for attracting funding or a c
CAPC
meds4life meds4life 6 minutes ago
Yup. "awaiting" could EASILY mean waiting to initiate contact with FDA.
AVXL
trading.jeff trading.jeff 6 minutes ago
No one GAF about slapping the thin ask. What does that say about the current state of affairs?

$APRU
APRU
srm4u srm4u 6 minutes ago
4u, it's been a while my friend.

I remember our last BK play and how well we did on that one.

Let's hope we hit another homerun here.
yes, it has.....i feel we have a no brainer here


Item 3. Financial Statements

The accompany
MGON
meds4life meds4life 6 minutes ago
Yup. "awaiting" could EASILY mean waiting to initiate contact with FDA.
AVXL
m0n m0n 6 minutes ago
Yup, we should see another one for the other new board member 

$TWOH
TWOH
TMaga TMaga 6 minutes ago
Don't worry, Clyde is making money. That's all that matters, isn't it ???
Clyde already paid himself $1 million to run a failed company and another $12 million in preferred shares he gave himself just before transferring all the assets from HCMC to this other SCAM.
More wardrobes for B
HCMC
m0n m0n 7 minutes ago
New 13G hit 

https://www.sec.gov/Archives/edgar/data/1494413/000126246325000016/xslF345X02/ownership.xml

TWOH

Your Recent History

Delayed Upgrade Clock